| scholarly article | Q13442814 |
| P50 | author | Xiang Gao | Q89334045 |
| Makedonka Mitreva | Q28805278 | ||
| P2093 | author name string | Jie Zhang | |
| John Martin | |||
| Zheng Chen | |||
| Lee Ratner | |||
| Daniel Kuritzkes | |||
| Bruce Rosa | |||
| Timothy Henrich | |||
| P2860 | cites work | Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | Q24619974 |
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity | Q24685633 | ||
| HIV-1 entry inhibitors: recent development and clinical use | Q27003887 | ||
| HIV: cell binding and entry | Q27008983 | ||
| Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env | Q27644383 | ||
| Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | Q27663293 | ||
| Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex | Q27679932 | ||
| Clinical significance of HIV-1 coreceptor usage | Q27691426 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| HIV entry and tropism: the chemokine receptor connection | Q41694886 | ||
| Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients | Q41991922 | ||
| Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor. | Q42239239 | ||
| gp120: Biologic aspects of structural features | Q43908516 | ||
| Trofile HIV co-receptor usage assay. | Q44470116 | ||
| Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially | Q51570780 | ||
| Reducing chimera formation during PCR amplification to ensure accurate genotyping | Q54411775 | ||
| Bioinformatics prediction of HIV coreceptor usage | Q80162610 | ||
| Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211 | Q80480588 | ||
| Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells | Q28288205 | ||
| Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data | Q29394572 | ||
| Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes | Q29619514 | ||
| HIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants | Q30836893 | ||
| Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo | Q33455862 | ||
| Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage | Q33711003 | ||
| Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping | Q34008448 | ||
| Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations | Q34301803 | ||
| Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism | Q34482589 | ||
| HIV-1 coreceptors and their inhibitors | Q34506596 | ||
| A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors | Q34606129 | ||
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
| Predicting HIV-1 coreceptor usage with sequence analysis. | Q35183379 | ||
| Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption | Q35190018 | ||
| HIV-1 integration landscape during latent and active infection | Q35211469 | ||
| Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms | Q35330357 | ||
| HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc | Q35662019 | ||
| Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance | Q35699612 | ||
| High throughput functional analysis of HIV-1 env genes without cloning | Q35940070 | ||
| HIV-1 gp120 V3 loop for structure-based drug design | Q36296646 | ||
| Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. | Q37667754 | ||
| Coreceptors and HIV-1 pathogenesis | Q37824291 | ||
| Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins | Q39075099 | ||
| Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. | Q39355095 | ||
| The second extracellular loop of CCR5 is the major determinant of ligand specificity. | Q39427062 | ||
| A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. | Q39460971 | ||
| Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers | Q39602726 | ||
| Evidence for Common Structural Determinants of Human Immunodeficiency Virus Type 1 Coreceptor Activity Provided through Functional Analysis of CCR5/CXCR4 Chimeric Coreceptors | Q39605336 | ||
| Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120. | Q40128614 | ||
| Structural basis for the interaction of CCR5 with a small molecule, functionally selective CCR5 agonist | Q40241635 | ||
| Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo | Q40308974 | ||
| Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences | Q40344458 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 198-214 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Evolution of coreceptor utilization to escape CCR5 antagonist therapy | |
| P478 | volume | 494 |
Search more.